Funded Tech Companies
Zelluna Immunotherapy
Wondering who provided funding to Zelluna Immunotherapy? Private investors and Takeda Ventures put venture money into this innovative biopharmaceutical company.
Company Overview
Company Name
Zelluna Immunotherapy
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Oslo Cancer Cluster Innovation Park Ullernchausséen 64
Oslo, 0379
Norway
Oslo, 0379
Norway
Phone
Website
Email Address
Company Background Information
Overview
Zelluna Immunotherapy is a biopharma company developing "off-the-shelf" T-cell receptor (TCR) guided natural killer (NK) cell therapy products for the treatment of multiple solid cancers. We are an expanding team of committed professionals who are constantly striving to improve the lives of patients and their families by developing new transformative treatments.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/30/2026
Financing History
Management Team
Title
Name
Email & Social
Chairman
Hans Robinson
Chief Executive Officer
Namir Hassan
Chief Financial Officer
Geir Melen
Chief Operating Officer
Anders Holm
Company Investors
- Takeda Ventures
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
The company data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs